Metformin Treatment of Hidradenitis Suppurativa: Effect on Metabolic Parameters, Inflammation, Cardiovascular Risk Biomarkers, and Immune Mediators
Hambly, Roisin, Kearney, Niamh, Hughes, Rosalind, Fletcher, Jean M, Kirby, Brian
Published in International journal of molecular sciences (01.04.2023)
Published in International journal of molecular sciences (01.04.2023)
Get full text
Journal Article
Cell‐free DNA is elevated in the serum of patients with hidradenitis suppurativa
Johnston, Daniel G. W., Hambly, Roisin, Kearney, Niamh, Tobin, Desmond J., Kirby, Brian
Published in Journal of dermatology (01.02.2023)
Published in Journal of dermatology (01.02.2023)
Get full text
Journal Article
Association of Biologic Treatment in Hidradenitis Suppurativa With Reduced Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio
Kearney, Niamh, McCourt, Collette, Hambly, Roisin, Hughes, Rosalind, O'Kane, Donal, Kirby, Brian
Published in JAMA dermatology (Chicago, Ill.) (01.02.2023)
Published in JAMA dermatology (Chicago, Ill.) (01.02.2023)
Get more information
Journal Article
40858 Mean neutrophil-to-lymphocyte ratio improves over time with guselkumab treatment vs. placebo in the VOYAGE 1 and VOYAGE 2 clinical trials
Kirby, Brian, Kearney, Niamh, Gorecki, Patricia, Buyze, Jozefien, Yang, Ya-Wen, Merola, Joseph
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
P106 Hidradenitis suppurativa is associated with lower socioeconomic status using the MacArthur scale of subjective social status
Kearney, Niamh, McGrath, Barry, McCourt, Collette, Hughes, Rosalind, O’Kane, Donal, Kirby, Brian
Published in British journal of dermatology (1951) (26.06.2023)
Published in British journal of dermatology (1951) (26.06.2023)
Get full text
Journal Article
O04 How useful is chest X-ray in addition to routine QuantiFERON® in the detection of latent tuberculosis prior to biologics?
Kearney, Niamh, Aslam, Fawad, Boyd, Grace, Boylan, Natasha, Laverty, Emma, O’Hare, Rosie, Campbell, Victoria, Hoey, Susannah, O’Kane, Donal
Published in British journal of dermatology (1951) (28.06.2024)
Published in British journal of dermatology (1951) (28.06.2024)
Get full text
Journal Article
P096 Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in moderate-to-severe plaque psoriasis: safety profile in older (≥ 65 years) and younger (< 65 years) patients in the phase III POETYK PSO-1, PSO-2 and long-term extension trials
Kearney, Niamh, Pink, Andrew, Hoyt, Kim, Kisa, Renata M, Banerjee, Subhashis, Rogers, Alexandra, Mullan, Jill, Warren, Richard B
Published in British journal of dermatology (1951) (28.06.2024)
Published in British journal of dermatology (1951) (28.06.2024)
Get full text
Journal Article
Treatment of hidradenitis suppurativa with adalimumab in the PIONEER I and II randomized controlled trials reduced indices of systemic inflammation, recognized risk factors for cardiovascular disease
Kearney, Niamh, Chen, Xin, Bi, Yingtao, Hew, Kinjal, Smith, Kathleen M, Kirby, Brian
Published in Clinical and experimental dermatology (14.08.2024)
Published in Clinical and experimental dermatology (14.08.2024)
Get full text
Journal Article
Treatment of hidradenitis suppurativa with adalimumab in the PIONEER I and II trials reduced indices of systemic inflammation, recognised risk factors for cardiovascular disease
Kearney, Niamh, Chen, Xin, Bi, Yingtao, Hew, Kinjal, Smith, Kathleen M, Kirby, Brian
Published in Clinical and experimental dermatology (14.08.2024)
Published in Clinical and experimental dermatology (14.08.2024)
Get full text
Journal Article